You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
29 June 2020
Stada is considering a range of options for launching its consumer healthcare products in the US but it is still “very early days” for the German company, says chief executive officer Peter Goldschmidt.
4 May 2020
Stada is stepping up its consumer healthcare presence in the Asia-Pacific region through a partnership with Yiling Pharmaceutical in China, an e-commerce initiative in China and a new subsidiary in Vietnam.
27 April 2020
Venture Life has signed an agreement with a Chinese partner, Stada has recruited from Google, and Bayer’s Supervisory Board has a new chairman following the departure of Werner Wenning after 54 years with the German company.
2 April 2020
Dermapharm has reported its financial results for 2019, Novartis and Aurobindo have terminated a transaction, and Stada has made a people appointment in Portugal.
16 March 2020
Stada’s Branded Products division reported sales up by 13% to EUR1.07 billion (USD1.16 billion) in 2019, despite falling sales in Russia.
5 March 2020
Stada says it is now the “clear market leader in Russia’s consumer healthcare sector” following recent acquisitions. The German company has just recruited Sandoz’ Stephan Eder as executive vice president of its business in Russia and the Commonwealth of Independent States (CIS).
24 February 2020
Germany’s Stada is strengthening its consumer healthcare presence in Europe by acquiring 15 brands – including Venoruton, Coldrex and Cetebe – from GlaxoSmithKline. The deal follows a series of acquisitions by Stada involving consumer healthcare assets.
12 February 2020
Germany’s Stada is strengthening its consumer healthcare presence in the Asia-Pacific region by acquiring the FERN C product portfolio in the Philippines for an undisclosed sum. The deal follows a series of European acquisitions by Stada.
12 February 2020
Stada has hired Aidan Fry – one of the driving forces behind the creation of the Generics Bulletin newsletter – as director of external communications.
3 February 2020
Bayer, Glanbia, Stada, Diapharm and the US Council for Responsible Nutrition (CRN) have recently announced people changes.